Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for XRN and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for XRN and 80,000+ other tickers.
See exactly how XRN's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for XRN and 80,000+ other tickers.
Chiron is a real estate investment trust focused on investing in and actively managing critical healthcare infrastructure. With more than a decade of experience as a public company, it has built a diversified portfolio anchored by strong tenants who deliver essential care in their communities nationwide.
BETHESDA, Md.--(BUSINESS WIRE)--Chiron Real Estate Inc. (NYSE: XRN) (the "Company" or "Chiron") today announced that it granted employment inducement awards to three executive officers who joined the Company in 2026.The awards will be issued on August 27, 2026 and, as previously approved in connection with each executive's commencement of employment with Chiron and as a material inducement to acceptance of employment with the Company, will consist of an aggregate of 80,000 stock options granted.
Chiron Real Estate is rated a Strong Buy, with its strategic pivot driving long-term re-rating potential. XRN's Q2 results showed strong progress: solid occupancy, portfolio recycling, and no major debt maturities until 2028, supporting flexibility amid transition. The SHOP pivot exposes XRN to higher operational risk and volatility, but industry tailwinds from demographic shifts and supply constraints offer significant upside.
BETHESDA, Md.--(BUSINESS WIRE)--Chiron Real Estate Inc. (NYSE: XRN) (the “Company” or “Chiron”) today announced the declaration of the Company's October, November and December 2026 common dividends and third quarter 2026 Series A and Series B preferred dividends. Declaration of October, November and December 2026 Common Dividends On August 18, 2026, the Board of Directors (the “Board”) declared a monthly common stock cash dividend of $0.16 per share for each of October, November and December of.
Chiron Real Estate reported second-quarter results as it continues to reposition its portfolio toward senior housing and away from outpatient medical real estate, with management emphasizing capital recycling, leadership additions and a growing investment pipeline. Chief Executive Officer Mark Decker Jr. said the company's existing portfolio remained operationally stable while it pursued a broader strategic
Chiron Real Estate Inc. (XRN) Q2 2026 Earnings Call Transcript